BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35922730)

  • 1. Factors associated with colorectal cancer screening adherence and the impact of COVID-19 on screening patterns in Connecticut, USA.
    Gangcuangco LMA; Rivas T; Basnet A; Ryu DY; Qaiser M; Usman R; Costales VC
    Intern Emerg Med; 2022 Nov; 17(8):2229-2235. PubMed ID: 35922730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population.
    Lee JK; Lam AY; Jensen CD; Marks AR; Badalov J; Layefsky E; Kao K; Ho NJ; Schottinger JE; Ghai NR; Carlson CM; Halm EA; Green B; Li D; Corley DA; Levin TR
    Gastroenterology; 2022 Sep; 163(3):723-731.e6. PubMed ID: 35580655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Évaluation de la gravité du cancer colorectal dépisté dans le contexte de la crise sanitaire liée au COVID19 en région Ile-de-France].
    Koïvogui A; Abihsera G; Le Trong T; Ait-Hadad H; Bernoux A; Delattre H; Vincelet C; Caroll R; Nicolet J
    Rev Epidemiol Sante Publique; 2023 Oct; 71(5):102124. PubMed ID: 37451076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of social determinants of health on colorectal cancer screening and surveillance in the COVID reopening phase.
    Choy AM; Lebwohl B; Krigel A
    Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):739-743. PubMed ID: 35102113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
    Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
    Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
    Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
    BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the COVID-19 pandemic on colorectal cancer screening in New York City.
    Lee B; Young S; Williams R; Liang PS
    J Med Screen; 2023 Jun; 30(2):81-86. PubMed ID: 36164282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in Colorectal Cancer Screening Practices in a Midwest Urban Safety-Net Healthcare System.
    Elangovan A; Skeans J; Lalani I; Ullah F; Roy A; Kaelber DC; Cooper GS; Sandhu DS
    Dig Dis Sci; 2021 Aug; 66(8):2585-2594. PubMed ID: 32816217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in uptake of stool-based colorectal cancer screening during the Covid-19 pandemic.
    Miller EA; Pinsky PF
    Cancer Causes Control; 2023 Oct; 34(10):887-895. PubMed ID: 37310565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
    de Jonge L; van de Schootbrugge-Vandermeer HJ; Breekveldt ECH; Spaander MCW; van Vuuren HJ; van Kemenade FJ; Dekker E; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    PLoS One; 2022; 17(6):e0270223. PubMed ID: 35749423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic disparities in colon cancer screening and adherence during the COVID-19 pandemic: a retrospective cohort analysis.
    Nwankwo EC; Hendrix C; Pollard K; Kallal C; Cruschiel T; Buckhold F; Hachem C
    Int J Colorectal Dis; 2022 Apr; 37(4):849-854. PubMed ID: 35275279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain).
    Vives N; Binefa G; Vidal C; Milà N; Muñoz R; Guardiola V; Rial O; Garcia M
    Prev Med; 2022 Feb; 155():106929. PubMed ID: 34954239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonoscopy screening and surveillance disparities during the COVID-19 pandemic.
    Randle HJ; Gorin A; Manem N; Feustel PJ; Antonikowski A; Tadros M
    Cancer Epidemiol; 2022 Oct; 80():102212. PubMed ID: 35816937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
    van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
    J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis.
    Toes-Zoutendijk E; de Jonge L; van Iersel CA; Spaander MCW; van Vuuren AJ; van Kemenade F; Ramakers CR; Dekker E; Nagetaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    Gut; 2023 Jul; 72(7):1319-1325. PubMed ID: 37076272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities.
    Nodora JN; Gupta S; Howard N; Motadel K; Propst T; Rodriguez J; Schultz J; Velasquez S; Castañeda SF; Rabin B; Martínez ME
    J Natl Cancer Inst; 2021 Aug; 113(8):962-968. PubMed ID: 32780851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of colorectal cancer screening with colonoscopy, including post-endoscopy events, among adults with Medicaid insurance.
    Fisher DA; Princic N; Miller-Wilson LA; Wilson K; Limburg P
    Curr Med Res Opin; 2022 May; 38(5):793-801. PubMed ID: 35243953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.